|

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

RECRUITINGN/ASponsored by Centre Henri Becquerel
Actively Recruiting
PhaseN/A
SponsorCentre Henri Becquerel
Started2025-11-07
Est. completion2026-03-15
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07285564

Summary

The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Signed informed consent
* Adult, male or female, aged 18 or over
* Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable
* Member or beneficiary of a social security plan

Exclusion Criteria:

* Child-Pugh C liver failure
* Patients under guardianship, conservatorship, or legal protection
* Patients deprived of their liberty
* Pregnant or breastfeeding women
* Hypersensitivity to 18F-FDG or any of its excipients (ethanol or water for injection)
* Uncontrolled diabetes
* Moderate to end-stage renal failure, stage IIIB to V (glomerular filtration rate less than 44 mL/min/1.73 m²)
* Patients unable to understand the study for any reason or to comply with the trial requirements (language, psychological, or geographical issues).

Conditions2

CancerHead Neck Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.